Recent Finacing
Recent Raise
SNIPR Biome is a Copenhagen-based clinical-stage biotech developing CRISPR-Cas-armed phages and engineered microbes to selectively kill or edit gut and airway bacteria, advancing SNIPR001 and microbiome therapeutics.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at SNIPR Biome.